Search Results

Gladstone Institutes and the Chan Zuckerberg Biohub signed an affiliation agreement to increase their research collaboration.

Astellas Pharma US, Inc. (“Astellas”) announced today the company has entered into a sponsored research agreement with the UMass Chan Medical School to proceed with research for an adeno-associated virus (AAV) vector mediated gene therapy for the treatment of Alexander disease, a fatal, ultra-rare disease for which the only current treatment option is supportive care.

The Empire State is seeing large infusions of funds from the state and the Chan Zuckerberg Initiative to develop therapies for cancer and other applications.

ixlayer, a leader in technology-based solutions for diagnostic testing, announced that its technology was selected by the Chan Zuckerberg Biohub and Stanford University to power their Community Alliance to Test Coronavirus at Home (CATCH) Study, a large-scale research collaboration led by Stanford Medicine for testing and tracking the coronavirus throughout the greater San Francisco Bay Area.

Connect Biopharma Holdings Limited announced today that Barry Quart, Chief Executive Officer, David Szekeres, President and Steven Chan, Chief Financial officer will be hosting one-on-one investor meetings at the Leerink Partners Inflammation and Immunology (I&I) and Metabolism Therapeutics Forum, taking place on July 9-10, 2024 in Boston, MA.